Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYFrontiers in immunology

Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report

  1. 1Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University , , ,
  2. 2State Key Laboratory of Biotherapy and Cancer Center, Sichuan University and Collaborative Innovation Center, West China Hospital , , ,

Related

  1. Combined Image-Based Profiling and Biochemical Analysis of GCaMP Overexpression Effects on Mammalian Cells
    L. L. Looger, L. Beebe, L. Tian
    bioRxivPreprintCC BY-NC-NDFull textCell biologybioRxiv
  2. Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
    Isabelle Ollivier-Hourmand, Manon Allaire, Jean Paul Cervoni +11
    Journal of HepatologyPeer-reviewedLicence not statedFull text17 citedGeneral biologyHAL
  3. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach
    Abbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié +10
    HepatologyPeer-reviewedLicence not statedFull text54 citedGeneral biologyHAL
  4. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
    Roser Pinyol, Sara Torrecilla, Huan Wang +32
    Journal of HepatologyPeer-reviewedLicence not statedFull text252 citedGeneral biologyHAL
  5. H3K18 lactylation promotes Treg/Th17 imbalance via PTPRM-STAT3 axis in hepatocellular carcinoma
    Jianwei Yi, Zhonghuo Chen, Hengchang Zhu +9
    iSciencePeer-reviewedCC BY-NC 4.0Full textImmunologyOncologyCell PressCrossrefEurope PMC
BibTeX
@article{xu2026gefitinibbased,
  title = {{Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report}},
  author = {Qin Xu and Xiaofen Li and Rui Zhu and Zirui Wang and Nuerye Tuerhonga and Chengjian Zhao and Yu Yang},
  journal = {Frontiers in immunology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655545},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
AU  - Qin Xu
AU  - Xiaofen Li
AU  - Rui Zhu
AU  - Zirui Wang
AU  - Nuerye Tuerhonga
AU  - Chengjian Zhao
AU  - Yu Yang
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in immunology
UR  - https://europepmc.org/article/PMC/PMC13655545
SN  - 1664-3224
ER  -